Poor Science; Poorly Trained Scientists; Poor Policies: Major Deterrents to the War on Cancer
- Authors
-
-
Leslie C. Costello
School of Dentistry Department of Oncology and Diagnostic Sciences and the Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland 21201, USA
-
- Keywords:
- Cancer, NIH policies, training of scientists, excessive molecular biology, holistic physiological/pathophysiological approach.
- Abstract
-
Although the availability of funding has been described as the major limitation on advances in cancer, the progress in the war on cancer has been deterred mainly by poor science, poorly trained scientists, and poor NIH policies. This is the result of NIH policies of its extreme focus on molecular biology (genomics, molecular genetics, molecular biology) identification of the molecular factors and pathways; which are required for the acceptability of treatment and preventive protocols. As such, this has influenced virtually all agencies that provide grants for medical research to adopt the NIH policies. This has impacted the funding of the research as well as the focus of the training of scientists. Directors of NCI Dr. Varmus (also Nobel Prize awardee) and Dr. Zerhouni had addressed this issue; and they rejected the necessity of molecular biology studies and information. NIH should return to the holistic physiological/pathophysiological approach to studies of cancer issues. This would provide the best approach for winning the war on cancer.
- Downloads
-
Download data is not yet available.
- References
-
Zerhouni E. The NIH roadmap. Science 2003; 332: 63-5. https://doi.org/10.1126/science.1091867
Leaf C. Why we're losing the war on cancer (and how to win it). Fortune 2004; 149(6): 76-82.
Costello LC. The effect of contemporary education and training of biomedical scientists on present and future medical research. Acad Med 2009; 84: 459-63. https://doi.org/10.1097/ACM.0b013e31819a7c6b
Perspective: Is NIH funding the "best science by the best scientists"? A critique of the NIH R01 research grant review policies. Acad Med 2010; 85(5): 775-9. https://doi.org/10.1097/ACM.0b013e3181d74256
National Institutes of Health. Enhancing Peer Review at NIH: Overview. Available at: http://enhancing-peer-review.nih.gov/index.html. Accessed January 18, 2010
Office of Extramural Research, National Institutes of Health. Encouraging Early Transition to Research Independence: Modifying the NIH New Investigator Policy to Identify Early Stage Investigators. Available at: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-08-121.html. Accessed January 18, 2010.
Bernard C. An Introduction to the Study of Experimental Medicine. New York, NY: The Macmillan Company 1927.
- Downloads
- Published
- 15-08-2018
- Issue
- Vol. 7 No. 3 (2018)
- Section
- Articles
How to Cite
Similar Articles
- Wei Zhang, Li-Wu Fu, ABC Transporters: Maintenance of the Cancer Stem Cell Phenotype , Journal of Cancer Research Updates: Vol. 3 No. 1 (2014)
- Yang-Hui Huang, Sung-Han Hsiao, Chung-Pu Wu, Isoreserpine Reverses Multidrug Resistance Mediated by ABCB1 , Journal of Cancer Research Updates: Vol. 4 No. 4 (2015)
- Anna Gu, Albert I. Wertheimer, The Many Aspects of Off-Label Prescribing in Oncology , Journal of Cancer Research Updates: Vol. 2 No. 2 (2013)
- Maria Teresa Piccolo, Stefania Crispi, The Dual Role Played by p21 May Influence the Apoptotic or Anti-Apoptotic Fate in Cancer , Journal of Cancer Research Updates: Vol. 1 No. 2 (2012)
- Jiangting Hu, Ern Yu Tan, Leticia Campo, Russell Leek, Zainina Seman, Helen Turley, Domenico Delia, Alfredo Cesario, Kevin Gatter, Francesco Pezzella, TRAP1 is Involved in Cell Cycle Regulated by Retinoblastoma Susceptibility Gene (RB1) in Early Hypoxia and has Variable Expression Patterns in Human Tumors , Journal of Cancer Research Updates: Vol. 2 No. 3 (2013)
- Sh.R. Kzyrgalin, R.S. Yamidanov, A.A. Rizvanov, Sh.Kh. Gantsev, Antitumor Activity of Dehydroxymethylepoxyquinomicin (DHMEQ) in Monotherapy and Combination with Cisplatin in the SKOV-3 Ovarian Cancer Model , Journal of Cancer Research Updates: Vol. 13 (2024)
- Yao Li, Meng-Ning Wei, Wen-Ji Zhang, Zhi Shi, A HPLC-UV Method for the Quantification of Regorafenib in Tumor , Journal of Cancer Research Updates: Vol. 9 No. 1 (2020)
- J. Kamal Vijetha, J. Anitha, M. Kanthi Thilaka, A Sisters Similarity Neural Network SSNN Model for Generalization and Detection of Mammographic Breast Cancer Lesion Abnormalities , Journal of Cancer Research Updates: Vol. 14 (2025)
- Parvin Mehdipour, Asaad Azarnezha, Eight-Hit Evolutionary Pattern in ATM Gene of a Breast Carcinoma Patient: A Personalized Approach , Journal of Cancer Research Updates: Vol. 10 (2021)
- Irene Ruiz, Freddy Fernando Durán, Carmen Sáez, Julián Sanz, Adela Pelayo, Fernando Moreno, Jorge Ruiz, Luis Ortega, Alejandro Pascual, HER2 Expression Discordance between Ductal Carcinoma In situ and Invasive Breast Carcinoma. How to Analyze Oncotype DX , Journal of Cancer Research Updates: Vol. 8 No. 1 (2019)
You may also start an advanced similarity search for this article.